Inotuzumab Ozogamicin and Low-Intensity Chemotherapy in Older Patients With Newly Diagnosed CD22 <sup>+</sup> Philadelphia Chromosome–Negative B-Cell Precursor Acute Lymphoblastic Leukemia - Concepedia

Concepedia

Publication | Closed Access

Inotuzumab Ozogamicin and Low-Intensity Chemotherapy in Older Patients With Newly Diagnosed CD22 <sup>+</sup> Philadelphia Chromosome–Negative B-Cell Precursor Acute Lymphoblastic Leukemia

30

Citations

24

References

2024

Year

Patrice Chevallier, Thibaut Leguay, Marc Delord, Cyril Šálek, Rathana Kim, Françoise Huguet, Yosr Hicheri, Ulla Wartiovaara‐Kautto, Emmanuel Raffoux, Thomas Cluzeau,

Journal of Clinical Oncology

Abstract

Our results support InO's use in first-line regimens for older patients with CD22<sup>+</sup> Ph- BCP-ALL.

References

	Year	Citations

Page 1